112
Participants
Start Date
June 30, 2004
Primary Completion Date
March 31, 2006
Study Completion Date
September 30, 2006
terlipressin
Placebo
Weill Cornell Medical Center, New York
Mount Sinai Medical Center/Mount Sinai Hospital, New York
Center for Liver Disease & Transplantation Clinic, New York
Hospital of the University of Pennsylvania, Philadelphia
Albert Einstein Medical Center, Philadelphia
Georgetown University Hospital, Washington D.C.
The Johns Hopkins Hospital, Baltimore
VCU Medical Center, Richmond
Medical University of South Carolina, Charleston
Mayo Clinic Jacksonville, Jacksonville
Methodist University Hospital, Memphis
Cleveland Clinic Foundation, Cleveland
Henry Ford Hospital, Detroit
Fairview-University Medical Center, Minneapolis
Mayo Clinic, Rochester
Northwestern Memorial Hospital, Chicago
Washington University School of Medicine, St Louis
Tulane University Health Sciences Center, New Orleans
St. Luke's Episcopal Hospital, St. Luke's Texas Liver Institute, Houston
University of Colorado Hospital & Health Sciences Center, Denver
Mayo Clinic Hospital, Phoenix
UCLA School of Medicine, Los Angeles
VA Medical Center, San Diego
California Pacific Medical Center, San Francisco
UC Davis Medical Center, Sacramento
University of Arizona College of Medicine, Tucson
UCSD Medical Center Hillcrest, San Diego
University of California, San Francisco, San Francisco
Yale New Haven Hospital, New Haven
VA CT Health Care System, West Haven
Lahey Clinic, Burlington
983285 Nebraska Medical Center, Omaha
University of Medicine & Dentistry of New Jersey - NJMS, Newark
The University of North Carolina at Chapel Hill, Chapel Hill
Oregon Health Sciences University, Portland
University of Texas Southwestern Medical Center of Dallas, Dallas
University of Washington Medical Center, Seattle
Lead Sponsor
Mallinckrodt
INDUSTRY